Gatifloxacin: profile and news

Antibiotic gatifloxacin (Tequin) poses health risks Mar 1, 2006
A study in the New England Journal of Medicine reports that the antibiotic gatifloxacin (Tequin) may increase the risk of both low blood sugar (hypoglycemia ... - MayoClinic.com

Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults Mar 1, 2006
Mamdani, Pharm.D., MPH. Background Gatifloxacin has been associated with both hypoglycemia and hyperglycemia. We examined dysglycemia ... - New England Journal of Medicine (subscription),

Antibiotic Found to Cause Blood-Sugar Ailments in Seniors Mar 2, 2006
Elderly patients taking the widely used antibiotic gatifloxacin were almost 17 times as likely to be hospitalized for very high blood sugar levels and four ... - Los Angeles Times,

Stronger Warnings for Tequin (gatifloxacin) Feb 16, 2006
...today announced labeling changes for Tequin (gatifloxacin), an antibiotic indicated for the treatment of patients with pneumonia, bronchitis, uncomplicated ... - DG News

Study warns of common antibiotic's glucose risks Mar 1, 2006
Gatifloxacin, sold under the brand name Tequin by manufacturer Bristol-Myers Squibb, is linked with an increased danger of blood sugar fluctuations when ... - CTV.ca,

Antibiotic raises blood sugar risk, study warns Mar 1, 2006
..."Gatifloxacin (the drug's generic name) is one member of a ... Several reports suggest that gatifloxacin is particularly prone to influence blood glucose levels.". ... - CTV.ca,

People with diabetes warned of antibiotic's side-effects Mar 1, 2006
...has found. The antibiotic gatifloxacin is sold under the brand name Tequin by its manufacturer, Bristol-Myers Squibb. Health Canada ... - CBC News,

Antibiotic can pose risk to elderly: Study Mar 1, 2006
The drug Tequin, also known as gatifloxacin, leads to an increased risk of hypoglycemia (low blood sugar) and hyperglycemia (high blood sugar) compared to ... - Toronto Star,

Study links popular antibiotic, serious blood sugar risks Mar 2, 2006
The study found the antibiotic gatifloxacin, sold under the brand name Tequin by manufacturer Bristol-Myers Squibb, is associated with an increased danger of ... - London Free Press,

Tequin usage associated with 17 times more risk of high blood ... Mar 2, 2006
...reserachers suggests. Tequin is chemically gatifloxacin and is manufactured by New York-based Bristol-Myers Squibb. Reserachers ... - Earthtimes.org

Antibiotic Can Cause Life-Threatening Blood Sugar Problems for ... Mar 1, 2006
...in the March 30 issue of The New England Journal of Medicine, is being released Wednesday because of last month's warning about Tequin (gatifloxacin) from the ... - Forbes

Study reveals risk to Tequin patients Mar 2, 2006
...antibiotic in question. Tequin (gatifloxacin), developed by Bristol-Myers Squibb, was federally approved in 1999. About 5,000 prescriptions ... - Newsday,

FDA issues new Tequin warning Feb 28, 2006
...infections. People with penicillin allergies use Tequin (gatifloxacin), a fluoroquinolone made by Bristol-Myers Squibb Company. ... - myDNA.com,

Tequin linked to blood sugar problems Mar 2, 2006
...and whose generic name is gatifloxacin, were more than four times as likely to seek such treatment for hypoglycemia, or low blood sugar. ... - United Press International

News in Brief Mar 1, 2006
The antibiotic gatifloxacin, sold under the brand name Tequin by manufacturer Bristol-Myers Squibb, is associated with an increased danger of both low blood ... - Hamilton Spectator,

Tequin Linked to High Risk of Dangerous Glucose Changes Mar 1, 2006
TORONTO, March 1 - The antibiotic Tequin (gatifloxacin) has been associated with a sharply elevated rate of hypoglycemia and hyperglycemia when older patients ... - MedPage Today,

Concerns About Antibiotic Mar 1, 2006
Researchers found the antibiotic gatifloxacin dramatically boosts the risk of potentially life-threatening blood sugar abnormalities. ... - 640 Toronto,

Clostridium difficile: Old Scourge Becomes Far Worse Feb 9, 2006
...identified molecular markers for increased virulence, and susceptibility to clindamycin and fluoroquinolones (levofloxacin, gatifloxacin, and moxifloxacin). ... - AAP Grand Rounds (subscription)

Indian Pharma going strong in third quarter Feb 23, 2006
...has been quite a good year for Zydus as it received approvals for Ribavirin Capsules, Promethazine Tablets and tentative approval for Gatifloxacin Tablets from ... - Express Pharma Pulse,

Health Canada Advises Diabetic Patients Not to Use the Antibiotic ... Feb 17, 2006
OTTAWA, CANADA -- February 17, 2006 -- Health Canada is advising diabetic patients, as a precaution, not to use the antibiotic Tequin (gatifloxacin) due to ... - DG News

Stronger warnings for antibiotic Tequin Feb 16, 2006
ROCKVILLE, Md., Feb. 16 (UPI) -- The Food and Drug Administration said Monday Bristol-Myers Squibb has bolstered its warnings for Tequin(gatifloxacin). ... - United Press International

Labeling Changes Strengthen Warnings For Tequin Feb 16, 2006
...announced on Thursday that it has changed the labeling for Tequin (gatifloxacin), an antibiotic used to treat pneumonia, bronchitis, uncomplicated gonorrhea ... - All Headline News

New combination treatment that could dramatically shorten the ... Jan 10, 2006
Conference on Antimicrobial Agents and Chemotherapy (ICAAC), held in Washington DC last month, heard that phase II trials of a gatifloxacin-containing regimen ... - News-Medical.net,

TT & Zydus Q3 results Jan 29, 2006
During the quarter under review, the group received approvals for Ribavirin Capsules, Promethazine Tablets and tentative approval for Gatifloxacin Tablets from ... - Business Standard,

New Drug Combination May Shorten TB Treatment Jan 17, 2006
The researchers replaced one of the four drugs in the combination currently used to treat TB. They replaced ethambutol with a drug called gatifloxacin. ... - Voice of America

E. Coli Defense Mechanism May Provide Key to Disrupting Bacteria ... Jan 16, 2006
...more severe cases of gastroenteritis, antibiotics such as erythromycin, clarithromycin, azithromycin ciprofloxacin, levofloxacin, gatifloxacin, or moxifloxacin ... - Newsinferno.com,

Tentative US FDA approval for Zydus Cadila's gatifloxacin tablets Nov 29, 2005
Mumbai: Cadila Healthcare Ltd has received tentative approval from the US FDA to market Gatifloxacin Tablets, 200mg and 400mg, a broad spectrum anti-bacterial ... - domain-B,

Zydus Cadila receives approval for Gatifloxacin Tablets from US ... Nov 29, 2005
Cadila Healthcare (Q, N,C,F)* Ltd has received tentative approval from the US FDA to market Gatifloxacin Tablets, 200 mg and 400 mg, a broad spectrum anti ... - Myiris.com,

Cadila gets USFDA nod for Gatifloxacin Nov 29, 2005
Cadila Healthcare has received a tentative US Food and Drug Administration (USFDA) approval to market Gatifloxacin tablets, 200 mg and 400 mg. ... - Business Standard,

Hypoglycemia associated with the use of gatifloxacin. Nov 15, 2005
We present the histories, clinical findings, and hospital course of three patients who developed hypoglycemia after receiving gatifloxacin. ... - HeartZine,

TB treatment and diagnostics pipeline: once empty, suddenly offers ... Dec 2, 2005
...interactions,тА? said Spigelman. One such drug is gatifloxacin, which is the furthest along in clinical development for tuberculosis. The drug ... - Aidsmap,

Zydus Cadila Receives Tentative Approval From US FDA Nov 29, 2005
Zydus Cadila has received a tentative approval from the US FDA (food and drug administration) to market Gatifloxacin tablets, 200 mg and 400 mg, a broad ... - Indlaw.com,

Sensex sheds 64 points Nov 29, 2005
Cadila Healthcare Ltd has received tentative approval from the US FDA to market Gatifloxacin Tablets, 200 mg and 400 mg, a broad spectrum anti-bacterial agent ... - Myiris.com,

New Epidemic Strain of C. difficile Seen Emerging in North America Dec 2, 2005
...type. All of the current BI/NAP1 isolates, and none of the historic isolates, were resistant to gatifloxacin and moxifloxacin. "If ... - Medscape (subscription)

PediaMed Recognized as One of Greater Cincinnati's Fastest-Growing ... Dec 6, 2005
...medicines in the field of allergy/cough/cold and in promoting TAZORAC(R) (tazarotene) acne cream and gel, ZYMAR(R) (gatifloxacin ophthalmic solution), and ... - Business Wire (press release),

Deadly Bacterial Illness May Be Spreading Dec 1, 2005
What's more, that strain also seems to have built resistance to gatifloxacin and moxifloxacin, which are two of the newest in a class of antibiotics commonly ... - CBS News

New intestinal bug emerging in North America Dec 2, 2005
The predominant strain was similar to that observed by McDonald's group and was resistant to ciprofloxacin, moxifloxacin, gatifloxacin and levofloxacin. ... - Reuters

Indices correct on weak global markets and profit booking Nov 29, 2005
Cadila Healthcare informed the exchanges that the company has received preliminary approval from the US FDA for the drug gatifloxacin in tablet form. ... - domain-B,

Deadly bacterial illness spreading Dec 2, 2005
That strain also seems to have built resistance to two of the newest in a class of antibiotics used in hospitals - gatifloxacin and moxifloxacin. ... - myDNA.com,

Deadly Bacterial Illness May Be Spreading Dec 2, 2005
WhatтАШs more, that strain also seems to have built resistance to gatifloxacin and moxifloxacin, which are two of the newest in a class of antibiotics commonly ... - Herald News Daily,

CDC: Deadly bacterial illness appears to be spreading Dec 1, 2005
What's more, the BI strain - as it is called - also seems to have built resistance to gatifloxacin and moxifloxacin, which are two of the newest in the ... - Kansas City Star,

Teva Gets FDA Nod on Gatifloxacin Oct 6, 2005
Cramer's Take) said the Food and Drug Administration granted tentative approval for the company's abbreviated new drug application for Gatifloxacin tablets. ... - TheStreet.com

Prospective Study Shows Gatifloxacin Triggers Hypoglycemia in ... Oct 11, 2005
SAN FRANCISCO, CA -- October 11, 2005 -- Gatifloxacin is significantly more likely than non-fluoroquinolones agents to induce hypoglycemia in elderly patients ... - DG News

FDA approves Teva's Gatifloxacin tablets Oct 9, 2005
TEVA) announced at the end of last week that the US Food and Drug Administration had granted tentative approval for its ANDA for Gatifloxacin tablets, 200 mg ... - Globes,

Teva Announces Tentative Approval of Gatifloxacin Tablets Oct 6, 2005
...(Nasdaq: TEVA) announced today that the US Food and Drug Administration has granted tentative approval for the Company's ANDA for Gatifloxacin Tablets, 200 mg ... - Genetic Engineering News,

IDSA: Link Between Tequin (gatifloxacin) and Hypoglycemia ... Oct 11, 2005
11 - Treatment with the fluoroquinolone Tequin (gatifloxacin) was strongly associated with hypoglycemia in elderly patients, particularly those with diabetes ... - MedPage Today,

Role of Systemic Antibiotics versus Intravitreal Antibiotics in ... Oct 25, 2005
Over the past 2 years, newer fourth-generation fluoroquinolones such as gatifloxacin and moxifloxacin have been shown to readily penetrate into the vitreous ... - DG News

Prospective Study Shows Gatifloxacin Triggers Hypoglycemia in ... 11 Oct 2005
SAN FRANCISCO, CA -- October 11, 2005 -- Gatifloxacin is significantly more likely than non-fluoroquinolones agents to induce hypoglycemia in elderly patients ... - DG News

IDSA: Link Between Tequin (gatifloxacin) and Hypoglycemia ... 11 Oct 2005
11 - Treatment with the fluoroquinolone Tequin (gatifloxacin) was strongly associated with hypoglycemia in elderly patients, particularly those with diabetes ... - MedPage Today,

Sunil Jain:Killer cure Sep 13, 2005
...are a large number of manufacturers, which normally ensure there are no price cartelsтАФthere are 101 producers of ciprofloxacin, 67 for gatifloxacin, 67 for ... - Business Standard,

Gatifloxacin as a Possible Cause of Serious Postoperative ... Aug 22, 2005
Address correspondence and reprint requests to Shane E. Brogan, MB, BCh, Department of Anesthesiology, University of Utah, Room 3C444, 30 North 1900 East, Salt ... - Anesthesia & Analgesia (subscription),

Bulk drug manufacturers face Chinese assault on home turf Sep 2, 2005
The drugs registered by the Chinese companies include Gatifloxacin, folic Acid, Progesterone BP/USP, Prazquantel BP/USP, Prazquantal, Cimitidine, febendazole ... - Financial Express,

Pediamed Appoints Chief Administrative Officer Aug 24, 2005
...tm) prescription medicines in the field of allergy/cough/cold and in promoting TAZORAC(r) acne cream and gel, ZYMAR(r) (gatifloxacin ophthalmic solution), and ... - PharmaLive.com (press release),

Ortho-McNeil: less is more with Levaquin Aug 9, 2005
...patients with moderate ABS and prior exposure to antibiotics, namely Bayer's [BAY.F] Avelox (moxifloxacin) and Bristol-Myers Squibb's [BMS] Tequin (gatifloxacin ... - Pharmaceutical Business Review

Update in General Internal Medicine Aug 5, 2005
40 mg/d) or intensive therapy (atorvastatin, 80 mg/ d). Patients were also randomly assigned to receive a monthly 10-day course of gatifloxacin or placebo in a ... - RedNova.com

PediaMed Launches Mobile Compliance Program For TAZORAC(R); New ... Jul 26, 2005
TM) prescription medicines in the field of allergy/cough/cold and in promoting TAZORAC(R) acne cream and gel, ZYMAR(R) (gatifloxacin ophthalmic solution), and ... - Business Wire (press release)

Select Access(TM) to Co-Promote Allergan's Zymar(R) to Primary ... Jul 19, 2005
...(NYSE: AGN - News) to co-promote Zymar┬о (gatifloxacin ophthalmic solution 0.3%), the first FDA-approved fourth generation topical fluoroquinolone indicated ... - Yahoo News (press release)

Select Access to Co-Promote Allergan's Zymar to Primary Care ... Jul 20, 2005
...to co-promote Zymar(R) (gatifloxacin ophthalmic solution 0.3%), the first FDA-approved fourth generation topical fluoroquinolone indicated for the treatment of ... - PharmaLive.com (press release)